Tech Company Financing Transactions

Alphyn Biologics Funding Round

Alphyn Biologics closed a $3.3 million Series A funding round on 9/19/2022. Investors included Queen City Angels, Angel Physicians Fund and Serial Stage Venture Partners.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The company intends to use the funds to conduct the Phase2a clinical trial of AB-101a, its lead candidate for the treatment of mild-to-moderate atopic dermatitis (AD), the most common form of eczema.

Company Information

Company Status
Private & Independent
Healthcare Services
Mailing Address
3724 Thomas Point Road
Annapolis, MD Undisclosed
Email Address
Alphyn is using its patent pending AB-101 platform biomaterial to target the most difficult, severe and prevalent skin diseases facing humankind. AB-101's first target disease is Atopic Dermatitis (or AD, also known as Eczema). AD is difficult to treat, can be very severe for many people and affects millions of people worldwide. A solution for AD is clearly needed.
Alphyn Biologics LinkedIn Company Profile
Social Media
Alphyn Biologics Company Twitter Account
Company News
Alphyn Biologics News
Alphyn Biologics on Facebook
Alphyn Biologics on YouTube

Management Team

Email & Social
Chief Executive Officer
Neal Koller
  Neal Koller LinkedIn Profile  Neal Koller Twitter Account  Neal Koller News  Neal Koller on Facebook
Chief Scientific Officer
Gary Pekoe
  Gary Pekoe LinkedIn Profile  Gary Pekoe Twitter Account  Gary Pekoe News  Gary Pekoe on Facebook
Steven Pentelnik
  Steven Pentelnik LinkedIn Profile  Steven Pentelnik Twitter Account  Steven Pentelnik News  Steven Pentelnik on Facebook



Browse more venture capital transactions:

Prev: 9/19/2022: 1MRobotics venture capital transaction
Next: 9/19/2022: Portabl venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary